Evidence map›Paper›PMID 33142775›Full record

ArticleMolecules (Basel, Switzerland)2020

María Angeles Pujante-Galián, Sergio A Pérez, Mercedes G Montalbán, Guzmán Carissimi, Marta G Fuster, Gloria Víllora, Gabriel García

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. RutheniumMolecules (Basel, Switzerland) · 2024
    Article
  3. A Comparison between BulgarianMolecules (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

María Angeles Pujante-GaliánInorganic Chemistry Department, Faculty of Chemistry, Regional Campus of International Excellence "Campus Mare Nostrum", University of Murcia, 30071 Murcia, Spain.
Sergio A PérezChemical Engineering Department, Faculty of Chemistry, Regional Campus of International Excellence "Campus Mare Nostrum", University of Murcia, 30071 Murcia, Spain.
Mercedes G MontalbánChemical Engineering Department, Faculty of Chemistry, Regional Campus of International Excellence "Campus Mare Nostrum", University of Murcia, 30071 Murcia, Spain.ORCID 0000-0003-1085-3042
Guzmán CarissimiChemical Engineering Department, Faculty of Chemistry, Regional Campus of International Excellence "Campus Mare Nostrum", University of Murcia, 30071 Murcia, Spain.ORCID 0000-0001-8808-7654
Marta G FusterChemical Engineering Department, Faculty of Chemistry, Regional Campus of International Excellence "Campus Mare Nostrum", University of Murcia, 30071 Murcia, Spain.
Gloria VílloraChemical Engineering Department, Faculty of Chemistry, Regional Campus of International Excellence "Campus Mare Nostrum", University of Murcia, 30071 Murcia, Spain.
Gabriel GarcíaInorganic Chemistry Department, Faculty of Chemistry, Regional Campus of International Excellence "Campus Mare Nostrum", University of Murcia, 30071 Murcia, Spain.
Universidad de Murcia · ES

Funding

Fundación Séneca 20977/PI/18Ministerio de Economía, Industria y Competitividad, Gobierno de España CTQ2017-87708-RMinisterio de Economía, Industria y Competitividad, Gobierno de España PRE2018-086441
6 · The paper itself

Abstract

In this work, the cytotoxic behavior of six ruthenium(II) complexes of stoichiometry [(η

Indexed as

AminophenolsAntineoplastic AgentsApoptosisCell ProliferationCoordination ComplexesCymenesDrug Screening Assays, AntitumorHeLa CellsHumansMCF-7 CellsNitrilesPyridazinesPyridinesRuthenium2-aminophenol4-aminophenol4-cyanopyridine4-cymeneAminophenolsAntineoplastic AgentsCoordination ComplexesCymenesNitrilespyridazinePyridazinesPyridinesRutheniumanticancer activitycomplexescytotoxicityMTT assayruthenium

Identifiers

PMID33142775
PMCPMC7662397
OpenAlexW3094845437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.